Twelve-month tolerability and efficacy study of np101, the sumatriptan iontophoretic transdermal system
Headache: The Journal of Head and Face Pain,  Clinical Article

Smith TR et al. – NP101, a transdermal sumatriptan formulation in development for the acute treatment of migraine, demonstrated tolerability and efficacy with successive uses over 12 months in this clinical trial.

Methods
  • Patients diagnosed with migraine who had participated in a randomized, double–blind, Phase III study of the NP101 patch were given the option to use NP101 to treat migraine episodes with moderate or severe headache pain for up to 12 months in this open–label trial.

Results
  • 183 patients applied 2089 study patches.
  • The most common adverse events involved the patch application site (45% of patients).
  • The only non–application–site adverse events reported in >2% of patients were nausea (n = 6, 3.3%), upper respiratory tract infection (n = 6, 3.3%), and nasopharyngitis (n = 4, 2.2%).
  • The incidence of triptan–associated adverse events was 1.6%.
  • Across all visits for investigator assessments, the majority of patients (ranging from 74.7% at Month 1 to 92.2% at Month 9) were scored as having no erythema at patch application sites.
  • For patient assessments, the percentage of patch placement sites scored as having no or minimal redness was 38.2% at the time of patch removal and 65.4% 24 hours after patch activation.
  • Two hours after patch activation across all patch treatments over the 12–month study, 23.8% of initial acute migraine episodes were scored as being free from headache pain, 58.2% as having headache pain relief,78.9% as nausea free, 60.1% as phonophobia free, 53.4% as photophobia free, and 20.7% as migraine free.
  • No evidence of waning tolerability or efficacy was observed over the 12–month study period.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pain Management

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pain Management Articles

1 Transforaminal versus parasagittal interlaminar epidural steroid injection in low back pain with radicular pain: a randomized, double-blind, active-control trial Full Text Pain Physician, July 23, 2014    Free full text

2 Prednisone for emergency department low back pain: A randomized controlled trial The Journal of Emergency Medicine, May 29, 2014    Clinical Article

3 Treatment of common low back pain: A new approach to an old problem Pain Practice, June 25, 2014    Clinical Article

4 Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: A systematic review and meta-analysis of randomized controlled trials Journal of Spinal Disorders & Techniques, June 30, 2014    Evidence Based Medicine    Review Article    Clinical Article

5 Transforaminal versus interlaminar approaches to epidural steroid injections: a systematic review of comparative studies for lumbosacral radicular pain Full Text Pain Physician, July 29, 2014    Free full text    Review Article

6 Catastrophizing - a prognostic factor for outcome in patients with low back pain: a systematic review The Spine Journal, July 17, 2014    Review Article

7 Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial Journal of Pain and Symptom Management, July 2, 2014    Clinical Article

8 Intradiscal methylene blue treatment for discogenic low back pain PM&R, May 2, 2014    Clinical Article

9 Buprenorphine–naloxone therapy in pain management Anesthesiology, April 25, 2014    Clinical Article

10 Is exercise effective for the management of neck pain and associated disorders or whiplash-associated disorders? A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration The Spine Journal, July 18, 2014    Evidence Based Medicine    Review Article

11 Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of easy-to-use clinical predictors of early response Pain Medicine, July 8, 2014    Clinical Article

12 The effectiveness of balneotherapy in chronic low back pain Clinical Rheumatology, March 11, 2014    Clinical Article

13 The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical trial Pain Practice, July 15, 2014    Clinical Article

14 CT-guided chemonucleolysis combined with psoas compartment block in lumbar disc herniation: a randomized controlled study Pain Medicine, July 11, 2014    Clinical Article

15 Dose-response and efficacy of spinal manipulation for care of chronic low back pain: a randomized controlled trial The Spine Journal, July 28, 2014    Clinical Article

16 Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial Neurology®, July 22, 2014    Clinical Article

17 Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain Pain, June 17, 2014    Clinical Article

18 Opioid combination: rationale and possible clinical applications Full Text Annals of Palliative Medicine, January 20, 2014    Free full text

19 Drug therapy for the treatment of chronic nonspecific low back pain: Systematic review and meta-analysis Full Text Pain Physician, November 26, 2013    Free full text    Evidence Based Medicine    Review Article    Clinical Article

20 Comparative effectiveness of lumbar transforaminal epidural steroid injections with particulate versus nonparticulate corticosteroids for lumbar radicular pain due to intervertebral disc herniation: A prospective, randomized, double-blind trial Pain Medicine, January 6, 2014    Clinical Article

Indexed Journals in Pain Management: more

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close